Smoking cessation in pregnancy

Expert Opinion on Drug Safety

Volumn 7, Issue 6, 2008, Pages 727-737

  Rore, Craig ^a   Brace, Vicki ^b   Danielian, Peter ^b   Williams, David ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b ABERDEEN MATERNITY HOSPITAL   (United Kingdom)

Author keywords

Bupropion; Nicotine; Nicotine replacement therapy; Pregnancy; Smoking cessation; Tobacco; Varenicline

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; MIRTAZAPINE; NICOPATCH; NICOTINE; NICOTINE GUM; NICOTINE PATCH; NIQUITIN CQ; PLACEBO; UNCLASSIFIED DRUG; VARENICLINE;

ADVERSE OUTCOME; BIRTH DEFECT; CLINICAL TRIAL; CONGENITAL MALFORMATION; DEPRESSION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CLEARANCE; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; HUMAN; MATERNAL SMOKING; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PATIENT COUNSELING; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; RECOMMENDED DRUG DOSE; REVIEW; SELF HELP; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SPONTANEOUS ABORTION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ANIMALS; BENZAZEPINES; BUPROPION; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; NICOTINE; NICOTINIC AGONISTS; PREGNANCY; PREGNANCY COMPLICATIONS; QUINOXALINES; SMOKING CESSATION;

EID: 57049156707     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740330802196756     Document Type: Review

References (71)

1. Medicines and Healthcare Products Regulation Agency. Report of the Committee on Safety of Medicines Working Group on Nicotine Replacement Therapy; 2005. Available from: hutp://www.mhra.gov.uk/Safetyinformation/ Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/ CON2022933
2. Aveyard P, West R. Managing smoking cessation. Br Med J 2007;335:37-41
3. Bosetti C, Gallus S, Garavello W, La Vecchia C. Smoking cessation and the risk of oesophageal cancer: an overview of published studies. Oral Oncol 2006;42:957-64
4. Willigendael EM, Teijink JA, Bartelink ML, et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg 2004;40:1158-65
5. Quik M. Smoking, nicotine and Parkinson's disease. Trends Neurosci 2004;27:561-8
6. Nabet C, Ancel P, Burguet A, Kaminski M. Smoking during pregnancy and preterm birth according to obstetric history: french national perinatal surveys. Paediatr Perinat Epidemiol 2005;19:88-96
7. Shiverick KT, Salafia C. Cigarette smoking and pregnancy. I: ovarian, uterine and placental effects. Placenta 1999;20:265-72
8. Odendaal HJ, Van Schie DL, De Jeu RM. Adverse effects of maternal cigarette smoking on preterm labor and abruptio placentae. Int J Gynecol Obstet 2001;74:287-8
9. Ananth CV, Smulian JC, Vintzileos AM. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies. Obstet Gynecol 1999;93:622-8
10. Saraiya M, Berg CJ, Kendrick JS, et al. Cigarette smoking as a risk factor for ectopic pregnancy. Obstet Gynecol 1998;178:493-8
11. Shah NR, Bracken MB. A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. Obstet Gynecol 2000;182:465-72
12. Haustein KO. Cigarette smoking, nicotine and pregnancy. Int J Clin Pharmacol Ther 1999;37:417-27
13. Milner AD, Rao H, Greenough A. The effects of antenatal smoking on lung function and respiratory symptoms in infants and children. Early Hum Dev 2007;83:707-11
14. Lannero E, Wickman M, Pershagen G, Nordvall SL. Maternal smoking during pregnancy increases the risk of recurrent wheezing during the first years of life (BAMSE). Respir Res 2006;7:1-6
15. Zlotkowska R, Zejda JE. Fetal and postnatal exposure to tobacco smoke and respiratory health in children. Eur J Epidemiol 2005;20:719-27
16. Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. The adverse effects of maternal smoking on the human placenta: a review. Placenta 2005;26:S81-6
17. Anderson GD, Blidner IN, McClemont S, Sinclair JC. Determinants of size at birth in a Canadian population. Obstet Gynecol 1984;150:236-44
18. England LJ, Kendrick JS, Gargiullo PM, et al. Measures of maternal tobacco exposure and infant birth weight at term. Am J Epidemiol 2001;153:954-60
19. MacArthur C, Knox EG. Smoking in pregnancy: effects of stopping at different stages. Br J Obstet Gynaecol 1988;95:551-5
20. Ness RB, Grisso JA, Hirschinger N, et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 1999;340:333-9
21. Mishra GD, Dobson AJ, Schofield MJ. Cigarette smoking, menstrual symptoms and miscarriage among young women. Aust N Z J Public Health 2000;24:413-20
22. Wisborg K, Kesmodel U, Henriksen TB, et al. A prospective study of maternal smoking and spontaneous abortion. Acta Obstet Gynecol Scand 2003;82:936-41
23. Wisborg K, Kesmodel U, Henriksen TB, et al. Exposure to tobacco smoke in utero and the risk of stillbirth and death in the first year of life. Am J Epidemiol 2001;154:322-7
24. Mitchell EA, Milerad J. Smoking and the sudden infant death syndrome. Rev Environ Health 2006;21:81-103
25. Stick S. The effects of in utero tobacco-toxin exposure on the respiratory system in children. Curr Opin Allergy Clin Immunol 2006;6:312-6
26. Morales-Suarez-Varela MM, Bille C, Christensen K, Olsen J. Smoking habits, nicotine use, and congenital malformations. Obstet Gynecol 2006;107:51-7
27. Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol 1999;181:1026-35
28. Ashmead GG. Smoking and pregnancy. J Matern Fetal Neonatal Med 2003;14:297-304
29. Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database Syst Rev 2005;CD001118.doi:10.1002/ 14651858.CD001118.pub2
30. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2005;CD001007.doi:10.1002/ 14651858.CD001007.pub2
31. Curry SJ, McBride C, Grothaus LC, et al. A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers. J Consult Clin Psychol 1995;63:1005-14
32. Borland R, Segan CJ, Livingston PM, Owen N. The effectiveness of callback counselling for smoking cessation: a randomized trial. Addiction 2001;96:881-889
33. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database of Syst Rev 2005;CD001292.doi:10.1002/ 14651858.CD001292.pub2
34. Rigotti NA, Park ER, Regan S, et al. Efficacy of telephone counseling for pregnant smokers: a randomized controlled trial. Obstet Gynecol 2006;108:83-92
35. Ussher M, West R, Hibbs N. A survey of pregnant smokers' interest in different types of smoking cessation support. Patient Educ Couns 2004;54:67-72
36. Abbot NC, Stead LF, White AR, Barnes J. Hypnotherapy for smoking cessation. Cochrane Database of Syst Rev 1998;CD001008.doi:10.1002/ 14651858.CD001008
37. White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev 2006;CD000009.doi:10.1002/14651858.CD000009.pub2
38. He D, Medbo JI, Hostmark AT. Effect of acupuncture on smoking cessation or reduction: an 8-month and 5-year follow-up study. Prev Med 2001;33:364-72
39. Bier ID, Wilson J, Studt P, Shakleton M. Auricular acupuncture, education, and smoking cessation: a randomized, sham-controlled trial. Am J Public Health 2002;92:1642-7
40. Ginzel KH, Maritz GS, Marks DF, et al. Critical review: nicotine for the fetus, the infant and the adolescent? J Health Psychol 2007;12:215-24
41. Luck W, Nau H, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharm Therapeut 1985;8:384-95
42. Eriksen PS, Gennser G, Lofgren O, Nilsson K. Acute effiects of maternal smoking on fetal breathing and movements. Obstet Gynecol 1983;61:367-72
43. Gennser G, Marsal K, Brantmark B. Maternal smoking and fetal breathing movements. Am J Obstet Gynecol 1975;123:861-7
44. Manning FA, Feyerabend C. Cigarette smoking and fetal breathing movements. Br J Obstet Gynaecol 1976;83:262-70
45. Mosier HD Jr, Jansons RA. Distribution and fate of nicotine in the rat fetus. Teratology 1972;6:303-11
46. Huang LZ, Hsiao S, Trzeciakowski J, et al. Chronic nicotine induces growth retardation in neonatal rat pups. Life Sci 2006;78:1483-93
47. Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Review. Drug Saf 2001;24:277-322
48. Bruner JP, Forouzan I. Smoking and buccally administered nicotine. Acute effect on uterine and umbilical artery Doppler flow velocity waveforms. J Reprod Med 1991;36:435-40
49. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 2000;96:967-71
50. Huang LZ, Wmzer-Serhan UH. Nicotine regulates mRNA expression of feeding peptides in the arcuate nucleus in neonatal rat pups. Dev Neurobiol 2007;67:363-77
51. Kapur B, Hackman R, Selby P, et al. Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Curr Therapeut Res Clin Exp 2001;62:274-8
52. Davidson P. Smoking habits, nicotine use, and congenital malformations 2. Obstet Gynecol 2006;107:1166-7
53. Le Houezec J, Benowitz NL. Smoking habits, nicotine use, and congenital malformations 1. Obstet Gynecol 2006;107:1166
54. Coleman T. Nicotine replacement therapy in pregnancy: use or avoid? J R Soc Promo Health 2005;125:210-1
55. Dempsey D, Jacob P III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002;301:594-8
56. Smith CL, Rivard EK, Edick CM. Smoking cessation therapy in pregnancy. J Pharm Technol 2006;22:161-7
57. ACOG. Committee Opinion, No. 316: smoking cessation during pregnancy. Obstet Gynecol 2005;106:883-8
58. GlaxoSmithKline UK. Zyban: summary of product characteristics. Available from: www.medicines.org.uk [Last accessed 4 November 2007]
59. Fryer JD, Lukas RJ. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. J Pharmacol Exp Ther 1999;288:88-92
60. Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 2000;295:321-7
61. Chun-Fai-Chan B, Koren G, Fayez I, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 2005;192:932-6
62. Thomson Micromedex. Bupropion: REPROTOX® database. Available from: http://www.thomsonhc.com [Last accessed 1 October 2007]
63. Cole JA, Modell JG, Haight BR, et al. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 2007;16:474-84
64. Potential effects of SSRIs and other antidepressants on newborns. WHO Drug Information 2004;18:221 Available from: http://82.77.46.154/gsdl/ whodruginfo/1.00.000/cl/CL1.18
65. GlaxoSmithKline The Bupropion Pregnancy Registry: Final Report, 1 September 1997 through 31 March 2008. Available from: http://pregnancyregistry.gsk.com/documents/bup_report_final_2008.pdf [Last accessed 27 September 2008]
66. Pfizer. Champix: summary of product characteristics. Available from: www.medicines.org.uk [Last accessed 1 October 2007]
67. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med 1995;333:1196-203
68. Pierre Fabre. Nicopatch: summary of product characteristics. Available from: www.medicines.org.uk [Last accessed 1 October 2007]
69. Novartis Consumer Health. Nicotinell: summary of product characteristics. Available from: www.medicines.org.uk [Last accessed 1 October 2007]
70. Pharmacia. Nicorette: summary of product characteristics. Available from: www.medicines.org.uk [Last accessed 1 October 2007]
71. GlaxoSmithKline Consumer Healthcare. Niquitin CQ: summary of product characteristics. Available from: www.medicines.org.uk [Last accessed 1 October 2007]